A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants
Clinical trial NCT03822754 · COMPLETED
Trial details
- NCT number
- NCT03822754
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-06
- Primary completion
- 2018-09-26
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.